77 related articles for article (PubMed ID: 7727280)
1. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria.
Mathews-Roth MM; Rosner B; Benfell K; Roberts JE
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):244-8. PubMed ID: 7727280
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of erythropoietic protoporphyria with cysteine.
Mathews-Roth MM; Rosner B
Photodermatol Photoimmunol Photomed; 2002 Dec; 18(6):307-9. PubMed ID: 12535027
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.
Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN
Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284
[TBL] [Abstract][Full Text] [Related]
5. [Erythropoietic protoporphyria: synopsis of 20 patients].
Lehmann P; Scharffetter K; Kind P; Goerz G
Hautarzt; 1991 Sep; 42(9):570-4. PubMed ID: 1938409
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
[TBL] [Abstract][Full Text] [Related]
9. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.
Harms JH; Lautenschlager S; Minder CE; Minder EI
Photochem Photobiol; 2009; 85(6):1434-9. PubMed ID: 19656325
[TBL] [Abstract][Full Text] [Related]
10. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LH; Kass EH
Arch Dermatol; 1977 Sep; 113(9):1229-32. PubMed ID: 900968
[TBL] [Abstract][Full Text] [Related]
11. Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases.
Mathews-Roth MM
Ann N Y Acad Sci; 1993 Dec; 691():127-38. PubMed ID: 8129282
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
14. Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study.
Timonen K; Kariniemi AL; Niemi KM; Teppo AM; Tenhunen R; Kauppinen R
J Am Acad Dermatol; 2000 Sep; 43(3):489-97. PubMed ID: 10954661
[TBL] [Abstract][Full Text] [Related]
15. Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine.
Bijlmer-Iest JC; Baart de la Faille H; van Asbeck BS; van Hattum J; van Weelden H; Marx JJ; Koningsberger JC
Photodermatol Photoimmunol Photomed; 1992-1993 Dec; 9(6):245-9. PubMed ID: 1343225
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria.
Boffa MJ; Ead RD; Reed P; Weinkove C
Photodermatol Photoimmunol Photomed; 1996 Feb; 12(1):27-30. PubMed ID: 8884896
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
19. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
Schnitzer TJ; Kamin M; Olson WH
Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
